• LAST PRICE
    69.7000
  • TODAY'S CHANGE (%)
    Trending Up1.5400 (2.2594%)
  • Bid / Lots
    60.0000/ 1
  • Ask / Lots
    86.7700/ 2
  • Open / Previous Close
    68.4700 / 68.1600
  • Day Range
    Low 68.3500
    High 69.8800
  • 52 Week Range
    Low 57.7700
    High 128.5100
  • Volume
    67,557
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 68.16
TimeVolumeLGND
09:32 ET24268.47
09:37 ET10068.35
09:51 ET10069.23
10:04 ET14569.44
10:09 ET20069.15
10:22 ET20369.3774
10:24 ET29469.5
10:26 ET20069.19
10:29 ET10069
10:40 ET19269
10:42 ET10568.69
10:49 ET20069.19
11:20 ET20069.27
11:43 ET30069.76
11:59 ET80069.5
12:01 ET10069.435
12:10 ET10069.57
12:14 ET140069.22
12:37 ET10069.5899
12:51 ET20069.58
01:02 ET63069.355
01:04 ET10069.35
01:06 ET10069.365
01:18 ET10069.32
01:27 ET10069.39
01:38 ET10069.35
01:44 ET20069.42
01:45 ET18569.39
01:49 ET10069.54
02:02 ET50069.45
02:12 ET10069.49
02:16 ET98069.67
02:43 ET100069.72
02:50 ET10069.614
03:12 ET40069.56
03:19 ET60069.56
03:21 ET10069.57
03:30 ET10069.64
03:32 ET10069.65
03:33 ET10069.6505
03:46 ET10069.78
03:48 ET70069.51
03:50 ET20069.27
03:51 ET109369.675
03:53 ET40069.565
03:55 ET50069.68
03:57 ET30069.79
04:00 ET208469.7
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLGND
Ligand Pharmaceuticals Inc
1.2B
-55.0x
---
United StatesTVTX
Travere Therapeutics Inc
1.4B
-5.4x
---
United StatesCDNA
CareDx Inc
784.3M
-10.7x
---
United StatesAGEN
Agenus Inc
722.1M
-3.3x
---
United StatesVCEL
Vericel Corp
1.3B
-71.6x
---
United StatesADPT
Adaptive Biotechnologies Corp
1.3B
-5.9x
---
As of 2023-01-31

Company Information

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company. It is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It has partnerships and license agreements with approximately 140 pharmaceutical and biotechnology companies and 400 programs are in various stages of commercialization, development, or research and are fully funded by its collaboration partners and licensees. The Company's OmniAb business segment is focused on enabling the discovery of therapeutic candidates for its partners by pairing antibody repertoires generated from its proprietary transgenic animals with its OmniAb business platform screening tools. The Company's Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. The OmniAb platform creates and screens diverse antibody pools and is designed to identify optimal antibodies.

Contact Information

Headquarters
3911 Sorrento Valley Blvd, Suite 110SAN DIEGO, CA, United States 92121
Phone
858-550-7500
Fax
302-636-5454

Executives

Non-Executive Independent Chairman of the Board
John Kozarich
President, Chief Operating Officer
Matthew Korenberg
Chief Executive Officer, Director
Todd Davis
Chief Financial Officer
Octavio Espinoza
Independent Director
Jason Aryeh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.2B
Revenue (TTM)
$241.7M
Shares Outstanding
16.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.10
EPS
$-1.27
Book Value
$48.97
P/E Ratio
-55.0x
Price/Sales (TTM)
4.8
Price/Cash Flow (TTM)
35.7x
Operating Margin
3.23%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.